Craig-Hallum Maintains Biodesix(BDSX.US) With Buy Rating
Scotiabank Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $3
Biodesix (BDSX) Receives a Buy From Scotiabank
Biodesix: Strong Growth Prospects Amidst Challenges Lead to Buy Rating
TD Cowen Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $3
Craig-Hallum Maintains Biodesix(BDSX.US) With Buy Rating
Craig-Hallum Maintains Biodesix(BDSX.US) With Buy Rating
Craig-Hallum Maintains Biodesix(BDSX.US) With Buy Rating
Craig-Hallum Maintains Biodesix(BDSX.US) With Buy Rating
Craig-Hallum Maintains Biodesix(BDSX.US) With Buy Rating
Lake Street Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $3
Craig-Hallum Maintains Biodesix(BDSX.US) With Buy Rating, Announces Target Price $3
Biodesix Analyst Ratings
Scotiabank Maintains Biodesix(BDSX.US) With Buy Rating, Cuts Target Price to $3
Scotiabank Initiates Biodesix at Sector Outperform With $3 Price Target
Lake Street Maintains Biodesix(BDSX.US) With Buy Rating, Maintains Target Price $3
Lake Street Sticks to Its Buy Rating for Biodesix (BDSX)
Craig-Hallum Maintains Biodesix(BDSX.US) With Buy Rating
Craig-Hallum Maintains Biodesix(BDSX.US) With Buy Rating
Biodesix Analyst Ratings
No Data
No Data